Allspring Global Investments’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-341,820
Closed -$547K 2812
2023
Q3
$547K Buy
+341,820
New +$944K ﹤0.01% 1507

Other funds holding RNLX

Allspring Global Investments's RNLX Position: Q4 2023 in Review

Allspring Global Investments sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 341,820 shares — an estimated $547K sold.

Allspring Global Investments first reported a position in RNLX in Q3 2023 and held it in 1 quarter. The position peaked at $547K in Q3 2023. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • Allspring Global Investments reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 341,820 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $547K.
  • Allspring Global Investments first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 1 quarter.
  • Allspring Global Investments's Renalytix plc American Depositary Shares position peaked at $547K in Q3 2023.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.